03:33 AM EDT, 09/13/2024 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on September 10, 2024, sold 30,000 shares in Halozyme Therapeutics ( HALO ) for $1,773,790. Following the Form 4 filing with the SEC, Torley has control over a total of 676,744 shares of the company, with 676,744 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924023307/xslF345X05/form4-09122024_090954.xml

Price: 60.00, Change: -0.54, Percent Change: -0.89